The availability of injecting paraphernalia in the UK following the 2003 law change to permit supply

References

• Abdulrahim D, Gordon D, Best D. Findings of a survey of needle exchanges in England. National Treatment Agency, London 2006
   Google Scholar
• Anonymous. (2005). Drug action team directory [online]. London: DrugScope. (Available at: http://www.drugscope.org.uk/home.asp–accessed 1 February 2005).
   Google Scholar
• Crofts N, Jolley D, Kaldor J, van Beek I, Wodak A. Epidemiology of hepatitis C virus infection among injecting drug users in Australia. Journal of Epidemiology and Community Health 1997; 51: 692–697
   PubMed Web of Science ®Google Scholar
• Denis B, Dedobbeleer M, Collet T, Petit J, Jamoulle M, Hayani A, et al. High prevalence of hepatitis C virus infection in Belgian intravenous drug users and potential role of the ‘cotton-filter’ in transmission: The GEMT Study. Acta gastro-enterological Belgica 2000; 63: 147–153
   PubMed Web of Science ®Google Scholar
• Edwards P, Roberts I, Clarke M, DiGuiseppi C, Pratap S, Wentz R, et al. Methods to influence response to postal questionnaires (Cochrane Methodology Review). In The Cochrane Library, Issue 4 (Cochrane library number: MR000008), Update Software, Oxford 2001
   Google Scholar
• Griesbach D, Abdulrahim D, Gordon D, Dowell K. Needle exchange provision in Scotland: A report of the national needle exchange survey. Scottish Executive, Edinburgh, UK 2006
   Google Scholar
• Hagan H, McGough JP, Thiede H, Weiss NS, Hopkins S, Alexander ER. Syringe exchange and risk of infection with hepatitis B and C viruses. American Journal of Epidemiology 1999; 149(3)203–213
   PubMed Web of Science ®Google Scholar
• Hagan H, Thiede H, Weiss NS, Hopkins SG, Duchin JS, Alexander ER. Sharing of drug preparation equipment as a risk factor for hepatitis C. American Journal of Public Health 2001; 91: 42–46
   PubMed Web of Science ®Google Scholar
• Hahn JA, Page-Shafer K, Lum PJ, Ochoa K, Moss AR. Hepatitis C virus infection and needle exchange use among young injection drug users in San Francisco. Hepatology 2001; 34: 180–187
   PubMed Web of Science ®Google Scholar
• Home Office. (2003). The Misuse of Drugs (Amendment) (No. 2) Regulations. Statutory Instrument, No. 1653. London: HMSO.
   Google Scholar
• Home Office. (2005). The Misuse of Drugs and the Misuse of Drugs (Supply to Addicts) (Amendment) Regulations. Statutory Instrument, No. 2864. London: HMSO.
   Google Scholar
• King LA. Drug content of powders and other illicit preparations in the UK. Forensic Science International 1997; 85: 135–147
   Web of Science ®Google Scholar
• Lucidarme D, Bruandet A, Ilef D, Harbonnier J, Jacob C, Decoster A, et al. Incidence and risk factors of HCV and HIV infections in a cohort of intravenous drug users in the north and east of France. Epidemiology and Infection 2004; 132: 699–708
   PubMed Web of Science ®Google Scholar
• Mathei C, Shkedy Z, Denis B, Kabali C, Aerts M, Molenberghs G, et al. Evidence for a substantial role of sharing of injecting paraphernalia other than syringes/needles to the spread of hepatitis C among injecting drug users. Journal of Viral Hepatitis 2006; 13: 560–570
   PubMed Web of Science ®Google Scholar
• Morley H. UK AIDS directory. National AIDS Manual, London 2004
   Google Scholar
• Parsons J, Hickman M, Turnbull PJ, McSweeney T, Stimson GV, Judd A, et al. Over a decade of syringe exchange: Results from 1997 UK survey. Addiction 2002; 97: 845–850
   PubMed Web of Science ®Google Scholar
• Ponton R, Scott J. Injection preparation processes used by heroin and crack cocaine injectors. Journal of Substance Use 2004; 9: 7–19
   Google Scholar
• Scott J, Kennedy EJ, Winfield AJ, Bond CM. Laboratory study of the effects of citric and ascorbic acids on injections prepared with brown heroin. International Journal of Drug Policy 2000; 11: 417–422
   PubMedGoogle Scholar
• Taylor A, Fleming A, Rutherford J, Goldberg D. Examining the injecting practices of injecting drug users in Scotland. Scottish Executive, Edinburgh, UK 2004
   Google Scholar
• Taylor A, Goldberg D, Hutchinson S, Cameron S, Gore SM, McMenamin J, et al. Prevalence of hepatitis C virus infection among injecting drug users in Glasgow 1990–1996: Are current harm reduction strategies working?. Journal of Infection 2000; 40(2)176–183
   PubMed Web of Science ®Google Scholar
• Thorpe LE, Ouellet LJ, Hershow R, Bailey SL, Williams IT, Williamson J, et al. Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment. American Journal of Epidemiology 2002; 155: 645–653
   PubMed Web of Science ®Google Scholar
• Villano SA, Vlahov D, Nelson KE, Lyles CM, Cohn S, Thomas DL. Incidence and risk factors for hepatitis C among injection drug users in Baltimore, Maryland. Journal of Clinical Microbiology 1997; 35: 3274–3277
   PubMed Web of Science ®Google Scholar